Table Of Contents
1 Introduction 23
1.1 Objectives Of The Study 23
1.2 Market Definition 23
1.3 Overview Of Global Antimicrobial Susceptibility Testing Market 23
1.4 Currency And Pricing 24
1.5 Limitation 24
1.6 Markets Covered 25
2 Market Segmentation 27
2.1 Markets Covered 27
2.2 Geographic Scope 28
2.3 Years Considered For The Study 29
2.4 Currency And Pricing 29
2.5 Research Methodology 30
2.6 Primary Interviews With Key Opinion Leaders 33
2.7 The Category Vs Time Grid 34
2.8 DBMR Market Challenge Matrix 35
2.9 Secondary Sources 36
2.10 Assumptions 36
3 Market Overview 37
3.1 Drivers 39
3.1.1 Increase In Number Of Infectious Disease 39
3.1.2 Technological Advancements In Antimicrobial Susceptibility Methods 40
3.1.3 Emergence Of Multidrug Resistance Due To Multiple Drug Use 41
3.1.4 Increased Funding, Research Grants, And Public-Private Investments 42
3.2 Restraints 43
3.2.1 High Cost Of Automated Antimicrobial Susceptibility Testing Systems 43
3.3 Opportunities44
3.3.1 Emerging Markets To Offer Lucrative Opportunities 44
3.3.2 Increase Awareness To Detect And Control Antimicrobial Resistance 45
3.4 Challenges 46
3.4.1 Lack Of Coordination Between Regulatory Bodies, Clinical Laboratories, And Ast Manufacturers 46
4 Executive Summary 47
5 Premium Insights 50
6 Global Antimicrobial Susceptibility Testing Market, By Product 52
6.1 Overview 53
6.2 Manual 55
6.2.1 Susceptibility Testing Disks 56
6.2.2 Mic Strips 57
6.2.3 Susceptibility Plates 57
6.2.4 Antimicrobial Susceptibility Testing Culture Media 58
6.2.5 Consumables 58
6.3 Automated 59
6.3.1 Susceptibility Plates 60
6.3.2 Automated Instruments 61
6.3.3 Susceptibility Plate Ancillaries 61
7 Global Antimicrobial Susceptibility Testing Market, By Methods 62
7.1 Overview 63
7.2 Dilution Methods 64
7.3 Disk Diffusion Method 65
7.4 E- Test 66
7.5 Genotypic Methods 68
7.6 Automated Systems 69
8 Global Antimicrobial Susceptibility Testing Market, By Application 70
8.1 Overview 71
8.2 Clinical Diagnostics 72
8.3 Drug Discovery And Development 73
8.4 Epidemiology 74
8.5 Others 76
9 Global Antimicrobial Susceptibility Testing Market, By End User 77
9.1 Overview 78
9.2 Hospitals 80
9.3 Pharmaceutical And Biotechnology Companies 82
9.4 Diagnostic Laboratories 83
9.5 Research And Academic Institutes 84
9.6 Contract Research Organizations 85
?
10 Global Antimicrobial Susceptibility Testing Market, By Geography 86
10.1 Global 87
10.2 North America 92
10.2.1 U.S. 99
10.2.2 Canada 103
10.2.3 Mexico 107
10.3 Europe 111
10.3.1 Germany 118
10.3.2 France 121
10.3.3 United Kingdom 124
10.3.4 Italy 127
10.3.5 Spain 130
10.3.6 Russia 133
10.3.7 Turkey 136
10.3.8 Belgium 139
10.3.9 Netherlands 142
10.3.10 Switzerland 145
10.3.11 Rest Of Europe 148
10.4 Asia-Pacific 149
10.4.1 Japan 156
10.4.2 China 160
10.4.3 India 164
10.4.4 South Korea 168
10.4.5 Australia 172
10.4.6 Singapore 176
10.4.7 Thailand 180
10.4.8 Malaysia 184
10.4.9 Indonesia 188
10.4.10 Philippines 192
10.4.11 Rest Of Asia-Pacific 196
10.5 South America 197
10.5.1 Brazil 204
10.5.2 Rest Of South America 207
10.6 Middle East & Africa 208
10.6.1 South Africa 215
10.6.2 Rest Of Middle East & Africa 219
?
11 Global Antimicrobial Susceptibility Testing Market,
Company Landscape 220
11.1 Company Share Analysis; Global 220
11.2 Company Share Analysis; North America 221
11.3 Company Share Analysis; Europe 222
11.4 Company Share Analysis; Asia-Pacific 223
12 Company Profiles 224
12.1 Biom?rieux Sa Company 224
12.1.1 Overview 224
12.1.2 Revenue Analysis 224
12.1.3 Company Share Analysis 225
12.1.4 Product Portfolio 225
12.1.5 Recent Developments 226
12.2 Thermo Fisher Scientific Inc. 228
12.2.1 Company Overview 228
12.2.2 Revenue Analysis 228
12.2.3 Company Share Analysis 229
12.2.4 Product Portfolio 229
12.2.5 Recent Developments 232
12.3 Bd 233
12.3.1 Company Overview 233
12.3.2 Revenue Analysis 233
12.3.3 Company Share Analysis 234
12.3.4 Product Portfolio 234
12.3.5 Recent Developments 235
12.4 Accelerate Diagnostics, Inc. 237
12.4.1 Company Overview 237
12.4.2 Revenue Analysis 237
12.4.3 Product Portfolio 237
12.4.4 Recent Developments 238
12.5 Alifax Holding S.P.A. 239
12.5.1 Company Overview 239
12.5.2 Geographic Presence 239
12.5.3 Product Portfolio 240
12.5.4 Recent Developments 240
?
12.6 Bio-Rad Laboratories Inc. 241
12.6.1 Company Overview 241
12.6.2 Revenue Analysis 241
12.6.3 Product Portfolio 242
12.6.4 Recent Developments 242
12.7 Bioanalyse Tibbi Malz. San. Ve Tic. Ltd. Sti. 243
12.7.1 Company Overview 243
12.7.2 Product Portfolio 243
12.7.3 Recent Developments 243
12.8 Conda 244
12.8.1 Company Overview 244
12.8.2 Geographic Presence 244
12.8.3 Product Portfolio 245
12.8.4 Recent Developments 246
12.9 Creative Diagnostics 247
12.9.1 Company Overview 247
12.9.2 Geographic Presence 247
12.9.3 Product Portfolio 248
12.9.4 Recent Developments 248
12.10 Genefluidics Inc.249
12.10.1 Company Overview 249
12.10.2 Product Portfolio 249
12.10.3 Recent Developments 249
12.11 Himedia Laboratories 250
12.11.1 Company Overview 250
12.11.2 Geographic al Presence 250
12.11.3 Product Portfolio 251
12.11.4 Recent Developments 252
12.12 Liofilchem Srl. 253
12.12.1 Company Overview 253
12.12.2 Product Portfolio 253
12.12.3 Recent Developments 254
12.13 Merck Millipore 255
12.13.1 Company Overview 255
12.13.2 Geographic Presence 255
12.13.3 Product Portfolio 256
12.13.4 Recent Developments 256
?
12.14 Zhuhai Dl Biotech. Co., Ltd 257
12.14.1 Company Overview 257
12.14.2 Product Portfolio 257
12.14.3 Recent Developments 257
13 Related Reports 258
?